Connecticut's Blumenthal questions Smart Choices
This article was originally published in The Tan Sheet
Executive SummaryConnecticut Attorney General Richard Blumenthal follows other government officials in raising concern about the food industry's Smart Choices, a voluntary nutrition labeling program. Blumenthal wrote letters to food firms that participate in the program, such as Kellogg Co. and General Mills, expressing his concern and requesting information on the development of the program. Executives from the Smart Choices program say they will work with Blumenthal, according to media reports. Rep. Rosa DeLauro, D-Conn., wrote a letter to FDA in September, asking the agency to investigate whether Smart Choices allows firms to misrepresent unhealthy food as healthy (1"The Tan Sheet" Sept. 28, 2009). FDA and the Department of Agriculture are also inquiring about the program
You may also be interested in...
The amyloid-targeting drug is years behind Biogen/Eisai’s aducanumab, but its subcutaneous administration and the GRADUATE studies’ design could give Roche’s gantenerumab an advantage.
Correvio's atrial fibrillation drug Brinavess will return to a US FDA advisory committee more than a decade after the agency first declined to approve the drug; FDA still has a series of cardiovascular safety concerns related to the drug and is not convinced by data from the European experience.